NCT01704729 (WEAR) is a NA clinical trial of group1 in Myopia, sponsored by Sun Yat-sen University.

Who is sponsoring NCT01704729?

NCT01704729 is sponsored by Sun Yat-sen University.

What drugs are being tested in NCT01704729?

Interventions in NCT01704729: group1, group2, group3, group4.

Is NCT01704729 still recruiting?

NCT01704729 is currently completed. Last updated 18 March 2021.

Last reviewed 2021-03-18 · How we verify

NCT01704729: WEAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Children's WEAR (Wearability and Evaluation of Adjustable Refraction) Trial(Phase 1&2)

Completed NA Last updated 18 March 2021

What this trial tests

NA trial testing group1 in Myopia in 2,300 participants. Completed in 1 April 2016.

Timeline

1 September 2012

Primary endpoint
1 April 2016

1 April 2016

Quick facts

Lead sponsor	Sun Yat-sen University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	2,300
Start date	1 September 2012
Primary completion	1 April 2016
Estimated completion	1 April 2016
Sites	1 location across China

Drugs / interventions tested

group1
group2
group3
group4

Conditions studied

Myopia — all drugs for Myopia →

Sponsor

Sun Yat-sen University

Who can join

Adults 12 to 17, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Visual acuity with and without study refractive correction
Time frame: 2 months

Sponsor's own description

Phase I: Focus groups on different designs of adjustable glasses and standard glasses (August-September 2012) Phase II: Two-month randomized trial comparing four groups: (September 2012 - August 2013)

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Interventions to slow progression of myopia in children.
Walline JJ, Lindsley KB, Vedula SS, Cotter SA, et al · · 2020 · cited 128× · PMID 31930781 · DOI 10.1002/14651858.cd004916.pub4
Interventions for myopia control in children: a living systematic review and network meta-analysis.
Lawrenson JG, Shah R, Huntjens B, Downie LE, et al · · 2023 · cited 117× · PMID 36809645 · DOI 10.1002/14651858.cd014758.pub2
Vision screening for correctable visual acuity deficits in school-age children and adolescents.
Evans JR, Morjaria P, Powell C. · · 2018 · cited 37× · PMID 29446439 · DOI 10.1002/14651858.cd005023.pub3

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Other Sun Yat-sen University trials

Trials by the same sponsor.

NCT07255612 — Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negat · Phase 2 · not yet recruiting
NCT07371897 — Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial · Phase 3 · not yet recruiting
NCT07489703 — SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC · Phase 2 · not yet recruiting
NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
NCT07522281 — Evaluation of an Undisturbed Embryo Culture System for Embryo Development in IVF/ICSI Cycles · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01704729 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sun Yat-sen University
Last refreshed: 18 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01704729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing